TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 29 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | -70.6% | 11,071 | -55.8% | 0.00% | – |
| Q3 2016 | $17,000 | -66.0% | 25,023 | +0.9% | 0.00% | – |
| Q2 2016 | $50,000 | +42.9% | 24,800 | +69.9% | 0.00% | – |
| Q1 2016 | $35,000 | -97.6% | 14,600 | -92.4% | 0.00% | – |
| Q4 2015 | $1,472,000 | +244.7% | 191,900 | +137.9% | 0.00% | – |
| Q3 2015 | $427,000 | +24.5% | 80,677 | +110.6% | 0.00% | – |
| Q2 2015 | $343,000 | +152.2% | 38,300 | +78.1% | 0.00% | – |
| Q1 2015 | $136,000 | -77.4% | 21,500 | -75.6% | 0.00% | – |
| Q3 2014 | $603,000 | – | 88,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|